Status:
COMPLETED
Effects of Projected Peripheral Defocus on Ocular Biometrics
Lead Sponsor:
Kubota Vision Inc.
Conditions:
Myopia
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
Acucela Inc. intends to develop a medical device to significantly halt or reverse myopic progression, which is a significant public health concern across the world, especially in Asian demographics. A...
Eligibility Criteria
Inclusion
- Spherical equivalent +2.00 to -4.00 diopters
- Refractive cylinder ≤ 0.75 diopters
- Visual acuity 20/20 -3 or better
Exclusion
- Pregnant or lactating
- Active ocular infection
- History of dry eye, strabismus, or amblyopia
- Previous or planned ocular surgery
- Use of medication known to affect vision or accommodation
Key Trial Info
Start Date :
April 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 14 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04388020
Start Date
April 11 2020
End Date
May 14 2020
Last Update
May 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manhattan Vision Associates/institute of Vision Research
New York, New York, United States, 10022